🇺🇸 FDA
Patent

US 9624303

Single-chain variable fragment anti-CD133 antibodies and uses thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 9624303 (Single-chain variable fragment anti-CD133 antibodies and uses thereof) held by Regents of the University of Minnesota expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P35/00